BIRC2 and cancer: However, due to the similarity of XIAP-, cIAP1-and cIAP2-BIR3 domains, also cIAP1/2 are efficiently targeted, which induces their proteasomal degradation and TNF-mediated cell death in cancer cells 15, 16.